Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin.

Leininger, E; Bowen, S; Renauld-Mongénie, G; Rouse, J H; Menozzi, F D; Locht, C; Heron, I; Brennan, M J

Leininger, E; Bowen, S; Renauld-Mongénie, G; Rouse, J H; Menozzi, F D; Locht, C; Heron, I; Brennan, M J.

Affiliation

Leininger E; Division of Bacterial Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.

J Infect Dis ; 175(6): 1423-31, 1997 Jun.

Article in En | MEDLINE | ID: mdl-9180182

Subject(s)

Adhesins, Bacterial/immunology; Bordetella pertussis/immunology; Hemagglutinins/immunology; Immunodominant Epitopes/analysis; Pertussis Vaccine/immunology; Virulence Factors, Bordetella; Amino Acid Sequence; Antibodies, Bacterial; Antibodies, Monoclonal; Child; Humans; Immune Sera; Infant; Molecular Sequence Data; Peptide Fragments/immunology; Recombinant Fusion Proteins/immunology; Vaccination; Whooping Cough/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bordetella pertussis / Virulence Factors, Bordetella / Pertussis Vaccine / Immunodominant Epitopes / Adhesins, Bacterial / Hemagglutinins Type of study: Prognostic_studies Limits: Child / Humans / Infant Language: En Journal: J Infect Dis Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links